McKinsey & Co to pay $550m over role in opioid crisis
On
February 5, 2021 -
At
2:25 pm
-
42
Views
McKinsey suggested ways to “turbocharge” sales of Purdue’s OxyContin painkiller at a time when the legal market for the opioid-based medicine was shrinking due to a wave of negative publicity, according to the Massachusetts Attorney General.
Read More